20250430_SB2308_3R Apr 30, 2025 Bill: SB2308 Caption: Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and the administration of that treatment. Vote Purpose: View Bill at Source: View Bill